A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Muscle stiffness, or rigidity, is another common early sign. It can happen in the arms, legs, or body and may feel like ...

A case-controlled study showed an alarming association between the odds of developing Parkinson’s disease (PD) and living ...

In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.